A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

September 30, 2012

Study Completion Date

October 31, 2012

Conditions
Coronary Artery DiseaseHeart Disease
Interventions
DRUG

Perflutren Lipid Microsphere Injectable Suspension

Activated DEFINITY 10ug/kg by bolus injection

Trial Locations (3)

32224

Local Institution, Jacksonville

55905

Local Institution, Rochester

85259

Local Institution, Scottsdale

Sponsors
All Listed Sponsors
lead

Lantheus Medical Imaging

INDUSTRY